Barbara Pro

Phase II trial of denileukin diftitox for relapsed/refractory T‐cell non‐Hodgkin lymphoma

Dan Jones, Maria A. Rodriguez, P. Mclaughlin, 2007, British journal of haematology.

Temsirolimus has activity in non-mantle cell non-Hodgkin's lymphoma subtypes: The University of Chicago phase II consortium.

Scott E. Smith, Eric Lester, Theodore Karrison, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Follicular lymphoma international prognostic index 2: a new prognostic index for follicular lymphoma developed by the international follicular lymphoma prognostic factor project.

Giovanni Martinelli, Stefano Luminari, Luigi Rigacci, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I study of bortezomib plus ICE (BICE) for the treatment of relapsed/refractory Hodgkin lymphoma

Yuan Ji, Paolo Anderlini, A. Younes, 2011, British journal of haematology.

Experience with heat shock protein‐peptide complex 96 vaccine therapy in patients with indolent non‐Hodgkin lymphoma

Y. Oki, P. Srivastava, P. Mclaughlin, 2007, Cancer.

Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.

Matthew Greenwood, Martin Wilhelm, B. Coiffier, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.